Standardization of PCR amplification for fragile X trinucleotide repeat measurements.
about
Molecular Correlates and Recent Advancements in the Diagnosis and Screening of FMR1-Related DisordersAdvanced technologies for the molecular diagnosis of fragile X syndromeConsensus characterization of 16 FMR1 reference materials: a consortium studyDNA diagnosis by capillary electrophoresis and microfabricated electrophoretic devices.An enhanced polymerase chain reaction assay to detect pre- and full mutation alleles of the fragile X mental retardation 1 gene.Developing a sustainable process to provide quality control materials for genetic testing.A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations.Advances in Huntington's disease diagnostics: development of a standard reference material.An improved Diagnostic PCR Assay for identification of Cryptic Heterozygosity for CGG Triplet Repeat Alleles in the Fragile X Gene (FMR1).Fragile X syndrome in Korea: a case series and a review of the literature.Methylation-specific multiplex ligation-dependent probe amplification enables a rapid and reliable distinction between male FMR1 premutation and full-mutation alleles.Polymerase chain reaction optimization for amplification of Guanine-Cytosine rich templates using buccal cell DNAHigh-throughput DNA diagnostic measurements using capillary electrophoresis: p53, fragile X and telomerase.Renewable standard reference material for the detection of TP53 mutations.Fragile X carrier screening in Korean women of reproductive age.FMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome.Age-related length variability of polymorphic CAG repeats.Association between the oxytocin receptor (OXTR) gene and autism: relationship to Vineland Adaptive Behavior Scales and cognition.Molecular diagnosis of Fragile X syndrome.Molecular testing for Fragile X Syndrome: lessons learned from 119,232 tests performed in a clinical laboratory.Genetic causes of intellectual disability in a birth cohort: a population-based study.
P2860
Q28077980-590E7B30-AE10-488E-8E4E-4F429CCCE821Q28087781-9745BCA2-5C79-4952-B314-CC404A7C810CQ30440559-B9D406A1-00D3-42F4-B415-505E2EB9C2F0Q35142190-B998FD36-E674-4F4E-92F1-2DAA85527975Q35790051-8FA15A58-A3CA-45BF-99AD-FC373025482CQ36296077-EBCF672A-F4EB-4222-AACD-16BFF2582341Q36329311-D39CBA23-8515-4876-BA9F-E843BCD54A9DQ36528887-CB48A244-564C-444A-A43E-F031DA910309Q36645376-374382A3-CC9E-4D41-93E0-066CE3321CD5Q36854528-26A54159-4E93-4470-B928-F3EAA2A1E315Q36944246-B30A6335-000F-427E-9CED-9B4BC8619343Q37043689-FC44DEC7-9C87-4C6A-BC3F-507FCD9E388CQ38088835-A17A4D43-6B70-47C2-A5E3-A764E082CDB0Q40622803-F0076BB8-D608-4B6B-A330-C01D0EA68F7EQ46579636-7B119ABB-C6F4-488E-A57A-60C2B45E178AQ47142098-95A6321A-C31A-4895-923D-D829ED1A4539Q48423508-8E56401D-3DD7-4FF0-8526-37C0C5AF2C7DQ50312431-CCBA8600-AA08-44FB-A794-45BEA3FD4EBAQ51667052-A57D6996-CF8C-4CBA-A087-0421A15A7D06Q51907966-373AB3CD-E331-4E14-A28C-2E2C1991B0FCQ53593000-D63034A4-DE2E-48FC-A490-41BA41CCB5E1
P2860
Standardization of PCR amplification for fragile X trinucleotide repeat measurements.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Standardization of PCR amplification for fragile X trinucleotide repeat measurements.
@en
type
label
Standardization of PCR amplification for fragile X trinucleotide repeat measurements.
@en
prefLabel
Standardization of PCR amplification for fragile X trinucleotide repeat measurements.
@en
P2093
P2860
P1433
P1476
Standardization of PCR amplification for fragile X trinucleotide repeat measurements.
@en
P2093
P2860
P356
10.1034/J.1399-0004.2002.610103.X
P577
2002-01-01T00:00:00Z